James S. Scott, Iacovos N. Michaelides and Markus Schade

RSC Med. Chem., 2025, 16, 449
DOI: 10.1039/D4MD00769G

Construction of sulfur-containing N-vinylimides: N-addition of imides to propargyl sulfonium salts

Shou-Jie Shen, Le-Mei Wang, Guo-Mei Gong, Yan-Jiao Wang, Jin-Yan Liang and Jun-Wen Wang

RSC Adv., 2022, 12, 12663
DOI: 10.1039/D2RA01117D

Preparation of von Hippel-Lindau (VHL) E3 ubiquitin ligase ligands exploiting constitutive hydroxyproline for benzylic amine protection

Diana M. Soto-Martínez, Garrett D. Clements, John E. Díaz, Joy Becher, Robert C. Reynolds, Christina Ochsenbauer and Timothy S. Snowden

RSC Adv., 2024, 14, 17077
DOI: 10.1039/D4RA01974A

Rapid synthesis of pomalidomide-conjugates in minutes via temperature elevation and delayed feeding

Yingying Jiang, Hang Zhao, Lunjie Chen, Siping Wei, Jun Wang, Lin Wang and Qiang Fu

Chem. Commun., 2025, 61, 5814
DOI: 10.1039/D5CC00611B

Efficient, multi-hundred-gram scale access to E3 ubiquitin ligase ligands for degrader development

Mark S. Cooper, Mark C. Norley, Simon Armitage, Joel O. Cresser-Brown, Anthony K. Edmonds, Sean Goggins, Jonathan P. Hopewell, Burhan Karadogan, Kevin A. Knights, Toby J. Nash, Catherine S. Oakes, William J. O'Neill, Simon J. Pridmore, Hannah J. Maple and Graham P. Marsh

Org. Biomol. Chem., 2023, 21, 8344
DOI: 10.1039/D3OB00983A

E3 ligase ligand chemistries: from building blocks to protein degraders

Izidor Sosič, Aleša Bricelj and Christian Steinebach

Chem. Soc. Rev., 2022, 51, 3487
DOI: 10.1039/D2CS00148A

Identification of ligand linkage vectors for the development of p300/CBP degraders

Duncan K. Brownsey, Ben C. Rowley, Evgueni Gorobets, Koichiro Mihara, Ranjan Maity, James W. Papatzimas, Benjamin S. Gelfand, Morley D. Hollenberg, Nizar J. Bahlis and Darren J. Derksen

RSC Med. Chem., 2022, 13, 726
DOI: 10.1039/D1MD00070E

Application of a bivalent “click” approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1)

Xue Zhi Zhao, Wenjie Wang, Md Rasel Al Mahmud, Keli Agama, Yves Pommier and Terrence R. Burke

RSC Med. Chem., 2025, 16, 1969
DOI: 10.1039/D4MD00824C

Microwave-assisted synthesis of pomalidomide building blocks for rapid PROTAC and molecular glue development

Diaaeldin I. Abdallah, Johan Israelian, Lina S. Hasan, Naman H. Patel, Jeffrey W. Keillor, Timothy B. Wright, Bilal Saqib, Elvin D. de Araujo and Patrick T. Gunning

Chem. Commun., 2025, 61, 4670
DOI: 10.1039/D4CC03435J

Utilising the intrinsic fluorescence of pomalidomide for imaging applications

Duncan K. Brownsey, Christopher J. Gafuik, Dae-Sun Kim, Leonie O’Sullivan, Evgueni Gorobets, Samuel Krukowski, Madison Turk, Craig N. Jenne, Douglas J. Mahoney and Darren J. Derksen

Chem. Commun., 2023, 59, 14532
DOI: 10.1039/D3CC04314B

Capsule-based automated synthesis for the efficient assembly of PROTAC like molecules

Samuele Bordi, Tuo Jiang, Anna Konopka, Guillaume Coin, Paula L. Nichols and Benedikt M. Wanner

Digital Discovery, 2023, 2, 848
DOI: 10.1039/D3DD00027C

A one-pot photocatalytic triazole-based linkerology for PROTACs

Jinhua Liu, Yaqi Deng, Jiabin Yin, Jian Ji, Cong Guan, Xuwen Chen, Xiang Wu, Tong Zhu and Shunying Liu

Cell Reports Physical Science, 2024, 5, 102139
DOI: 10.1016/j.xcrp.2024.102139

PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications

Narayanaperumal Pravin and Krzysztof Jóźwiak

European Journal of Medicinal Chemistry, 2024, 279, 116837
DOI: 10.1016/j.ejmech.2024.116837

E3 Ligase Ligands in Successful PROTACs: An Overview of Syntheses and Linker Attachment Points

Aleša Bricelj, Christian Steinebach, Robert Kuchta, Michael Gütschow and Izidor Sosič

Front. Chem., 2021, 9
DOI: 10.3389/fchem.2021.707317

Proteolysis Targeting Chimera Degraders of the METTL3–14 m6A-RNA Methyltransferase

Francesco Errani, Annalisa Invernizzi, Marcin Herok, Elena Bochenkova, Fiona Stamm, Ivan Corbeski, Valeria Romanucci, Giovanni Di Fabio, František Zálešák and Amedeo Caflisch

JACS Au, 2024, 4, 713
DOI: 10.1021/jacsau.4c00040

Influence of Linker Attachment Points on the Stability and Neosubstrate Degradation of Cereblon Ligands

Aleša Bricelj, Yuen Lam Dora Ng, Dominic Ferber, Robert Kuchta, Sina Müller, Marius Monschke, Karl G. Wagner, Jan Krönke, Izidor Sosič, Michael Gütschow and Christian Steinebach

ACS Med. Chem. Lett., 2021, 12, 1733
DOI: 10.1021/acsmedchemlett.1c00368

A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions

Le Guo, Yaxian Zhou, Xueqing Nie, Zhongrui Zhang, Zhen Zhang, Chunrong Li, Taobo Wang and Weiping Tang

European Journal of Medicinal Chemistry, 2022, 236, 114317
DOI: 10.1016/j.ejmech.2022.114317

Advancing Strategies for Proteolysis-Targeting Chimera Design

Minglei Li, Ying Zhi, Bo Liu and Qingqiang Yao

J. Med. Chem., 2023, 66, 2308
DOI: 10.1021/acs.jmedchem.2c01555

Phenotypic Screening for Targeted Protein Degradation: Strategies, Challenges, and Emerging Opportunities

Baoli Ding, Jiawen Hu, Binyan Shou, Li Jiang, Bo Yang, Ji Cao and Cheng-Liang Zhu

J. Med. Chem., 2025, 68, 18024
DOI: 10.1021/acs.jmedchem.5c00949

Modulating the Potency of BRD4 PROTACs at the Systems Level with Amine-Acid Coupling Reactions

Andrew McGrath, Haiyan Huang, Jean-Francois Brazeau, Zirong Zhang, Christopher O. Audu, Nadeem A. Vellore, Lu Zhu, Zhicai Shi, Jennifer D. Venable, Christine F. Gelin and Tim Cernak

J. Med. Chem., 2025, 68, 405
DOI: 10.1021/acs.jmedchem.4c02047

Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures

Mateusz P. Plesniak, Emilia K. Taylor, Frederik Eisele, Christopher M. B. K. Kourra, Iacovos N. Michaelides, Alice Oram, Johan Wernevik, Zulma Santisteban Valencia, Hannah Rowbottom, Nadia Mann, Linda Fredlund, Valentyna Pivnytska, Anna Novén, Mohammad Pirmoradian, Thomas Lundbäck, R. Ian Storer, Mariell Pettersson, Gian M. De Donatis and Marie Rehnström

ACS Med. Chem. Lett., 2023, 14, 1882
DOI: 10.1021/acsmedchemlett.3c00314

Applications and Limitations of Oxime‐Linked “Split PROTACs”

Weijun Gui and Thomas Kodadek

ChemBioChem, 2022, 23
DOI: 10.1002/cbic.202200275

One-Pot Synthesis of Cereblon Proteolysis Targeting Chimeras via Photoinduced C(sp2)–C(sp3) Cross Coupling and Amide Formation for Proteolysis Targeting Chimera Library Synthesis

Christine M. Arndt, Jacqueline Bitai, Jessica Brunner, Till Opatz, Paola Martinelli, Andreas Gollner, Kevin R. Sokol and Matthias Krumb

J. Med. Chem., 2023, 66, 16939
DOI: 10.1021/acs.jmedchem.3c01613

Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs

Christian Steinebach, Aleša Bricelj, Arunima Murgai, Izidor Sosič, Luca Bischof, Yuen Lam Dora Ng, Christopher Heim, Samuel Maiwald, Matic Proj, Rabea Voget, Felix Feller, Janez Košmrlj, Valeriia Sapozhnikova, Annika Schmidt, Maximilian Rudolf Zuleeg, Patricia Lemnitzer, Philipp Mertins, Finn K. Hansen, Michael Gütschow, Jan Krönke and Marcus D. Hartmann

J. Med. Chem., 2023, 66, 14513
DOI: 10.1021/acs.jmedchem.3c00851

Harnessing Oxetane and Azetidine Sulfonyl Fluorides for Opportunities in Drug Discovery

Oliver L. Symes, Hikaru Ishikura, Callum S. Begg, Juan J. Rojas, Harry A. Speller, Anson M. Cherk, Marco Fang, Domingo Leung, Rosemary A. Croft, Joe I. Higham, Kaiyun Huang, Anna Barnard, Peter Haycock, Andrew J. P. White, Chulho Choi and James A. Bull

J. Am. Chem. Soc., 2024, 146, 35377
DOI: 10.1021/jacs.4c14164

Rapid Discovery of Celastrol Derivatives as Potent and Selective PRDX1 Inhibitors via Microplate-Based Parallel Compound Library and In Situ Screening

Shuang Chen, Zhenyu Wang, Jia Gao, Yanlin Wang, Jiayin Liang, Yingshuang Zhu, Heng Xu, Kaixian Chen, Lu Jin, Hao Zhang, Huan Xiong and Cheng Luo

J. Med. Chem., 2025, 68, 13609
DOI: 10.1021/acs.jmedchem.5c00433

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit Generation

Jean Quancard, Anna Vulpetti, Anders Bach, Brian Cox, Stéphanie M. Guéret, Ingo V. Hartung, Hannes F. Koolman, Stefan Laufer, Josef Messinger, Gianluca Sbardella and Russell Craft

ChemMedChem, 2023, 18
DOI: 10.1002/cmdc.202300002

The synthesis of 1,2,3-triazoles as binders of D-dopachrome tautomerase (D-DT) for the development of dual-targeting inhibitors

Angelina Osipyan, Radu-George Bulai, Zhengyang Wu, Jarno de Witte, Jesse J.H. van der Velde, Mohammed Kader, Petra E. van der Wouden, Gerrit J. Poelarends and Frank J. Dekker

European Journal of Medicinal Chemistry, 2024, 276, 116665
DOI: 10.1016/j.ejmech.2024.116665

ID Card of Mcl-1 PROTAC degrader: From in silico design to biological validation in chemoresistant ovarian cancer

Marie Cornu, Jocelyn Pezeril, Nicolas Guedeney, Hippolyte Paysant, Thomas Lemaitre, Florian Schwalen, Romane Florent, Julie N'Guyen, Sophie Corvaisier, Marc Since, Dimitri Fayolle, Amina Hamza, Mike Maillasson, Jana Sopkova-de Oliveira Santos, Charline Kieffer, Laurent Poulain and Anne Sophie Voisin-Chiret

European Journal of Medicinal Chemistry Reports, 2026, 17, 100336
DOI: 10.1016/j.ejmcr.2026.100336

A practical “preTACs-cytoblot” platform accelerates the streamlined development of PROTAC-based protein degraders

Zijian Rao, Kailin Li, Ju Hong, Danni Chen, Baoli Ding, Li Jiang, Xuxin Qi, Jiawen Hu, Bo Yang, Qiaojun He, Xiaowu Dong, Ji Cao and Cheng-Liang Zhu

European Journal of Medicinal Chemistry, 2023, 251, 115248
DOI: 10.1016/j.ejmech.2023.115248

Photoredox Csp3−Csp2 Reductive Cross‐Couplings of Cereblon Ligands for PROTAC Linker Exploration in Batch and Flow

Alexander Steiner, Johannes Krieger, Reinaldo Jones, Dietrich Böse, Yanping Wang, Hans‐Michael Eggenweiler, Jason D. Williams and C. Oliver Kappe

ChemCatChem, 2022, 14
DOI: 10.1002/cctc.202201184

Development of Rapid and Facile Solid‐Phase Synthesis of PROTACs via a Variety of Binding Styles

Hanqiao Xu, Takashi Kurohara, Reina Takano, Hidetomo Yokoo, Norihito Shibata, Nobumichi Ohoka, Takao Inoue, Mikihiko Naito and Yosuke Demizu

ChemistryOpen, 2022, 11
DOI: 10.1002/open.202200131

A Versatile and Sustainable Multicomponent Platform for the Synthesis of Protein Degraders: Proof-of-Concept Application to BRD4-Degrading PROTACs

Irene Preet Bhela, Alice Ranza, Federica Carolina Balestrero, Marta Serafini, Silvio Aprile, Rita Maria Concetta Di Martino, Fabrizio Condorelli and Tracey Pirali

J. Med. Chem., 2022, 65, 15282
DOI: 10.1021/acs.jmedchem.2c01218

Electrochemical platform based on Ti3C2Tx MXene-supported molecularly imprinted polymers for low-level and selective pomalidomide monitoring

Cansu Sanli, Ahmed Isa, Ahmet Cetinkaya, Havva Nur Gurbuz, Yahya Sorkhe, M. Altay Unal, Aytekin Uzunoglu, Esen Bellur Atici and Sibel A. Ozkan

Analytica Chimica Acta, 2026, 1405, 345464
DOI: 10.1016/j.aca.2026.345464

Strengthening Molecular Glues: Design Strategies for Improving Thalidomide Analogs as Cereblon Effectors and Anticancer Agents

Michael J Nutt and Scott G Stewart

Drug Discovery Today, 2024, 29, 104010
DOI: 10.1016/j.drudis.2024.104010

Accelerated synthesis of immunomodulatory imide drugs and their derivatives via continuous flow chemistry

Tianyi Hou, Junrong Huang, Yongheng Li, Yuxiang Zhu, Hengzhi You and Fen-Er Chen

Commun Chem, 2026, 9
DOI: 10.1038/s42004-026-01956-1

Photocatalytic Multiple Deuteration of Polyethylene Glycol Derivatives Using Deuterium Oxide

Riku Ogasahara, Miyu Mae, Keisuke Matsuura, Sota Yoshimura, Takayoshi Ishimoto, Taro Udagawa, Kazuo Harada, Hiroyoshi Fujioka, Mako Kamiya, Rio Asada, Hiromasa Uchiyama, Yuichi Tozuka, Shuji Akai and Yoshinari Sawama

Chemistry A European J, 2025, 31
DOI: 10.1002/chem.202404204

Design, Synthesis, and Biological Evaluation of Selective TBL1X Degraders

Rui Yang, Betsy Pray, Lapo Alinari, Pui Kai Li and Xiaolin Cheng

ACS Med. Chem. Lett., 2024, 15, 1699
DOI: 10.1021/acsmedchemlett.4c00255

Accelerating the Discovery of Targeted Protein Degraders: Advances in Synthetic Methodologies and Screening Tactics

Baoli Ding, Xiaotong Chen, Yulu Chen, Ji Cao, Bo Yang, Li Jiang and Cheng‐Liang Zhu

Chemistry A European J, 2026
DOI: 10.1002/chem.202503641

Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs

André T. S. Vicente, Sara P. S. P. Moura and Jorge A. R. Salvador

Commun Chem, 2025, 8
DOI: 10.1038/s42004-025-01598-9

Lessons learned in linking PROTACs from discovery to the clinic

Andy Pike, Esther C. Y. Lee, Iacovos N. Michaelides, Markus Schade, Ankit Sharma, James S. Scott and Abhishek Srivastava

Nat Rev Chem, 2025, 10, 117
DOI: 10.1038/s41570-025-00784-6

Alkyne Two-Phase Strategy: Rapid Generation of TK-285-Derived PROTACs as BRD4 Degraders

Hiroyuki Yamakoshi, Ryo Watanabe, Ryosuke Segawa, Ryosuke Ishihara, Ryo Tachibana, Genki Kudo, Shota Nagasawa, Satoshi Yamanaka, Ayano Ito, Hiroyuki Takeda, Tatsuya Sawasaki, Ryunosuke Yoshino, Takatsugu Hirokawa, Takayuki Doi, Noriyasu Hirasawa and Yoshiharu Iwabuchi

J. Med. Chem., 2026, 69, 8388
DOI: 10.1021/acs.jmedchem.5c03771